August 18, 2005
Systems Analytics Receives Series A Venture Investment Fund
Needham, MA. - Systems Analytics, Inc., a Massachusetts based bioinformatics technology development company, announced today (Thursday, 08/18) that it has closed a Series A round of venture financing that will allow the company to further develop and commercialize its bioinformatics technology.
The investor leading this round is AllSmart Development Limited. The majority of the funds will be used to develop and commercialize Systems Analytics’ bioinformatics capabilities that performs integrated analysis with genomics, proteomics, and metabolomics data profiles obtained from sources such as blood/plasma, urine, biopsy/tissue, spinal fluid, etc, and provides needed information to users from a large variation of applications in a systems biology approach.
Systems Analytics’ mission is to discover biomarkers of clinical and scientific significance by developing, improving and applying genomics, proteomics, metabolomics, and bioinformatics technologies. The objective of the discovery will focus on biomarkers for the early detection, treatment, and management of disease and toxicological effects upon external and internal impact, and on the understanding of the biological mechanisms.